Description
CELLINK RGD contains alginate covalently conjugated with RGD, the cell-attachment peptide sequence, and nanofibrillated cellulose, jointly patented by UPM-Kymmene Corporation and CELLINK Bioprinting AB, providing excellent printability and supporting 3D cell culture of a wide range of cell types. CELLINK RGD crosslinks easily with CaCl₂ Crosslinking Agent, creating stable and supportive constructs.
Specifications
| Appearance | White semi-translucent gel |
| Sterility | Sterile |
| pH |
6.5-7.4 |
| Viscosity | 2.6-7.5 kPa∙s at 0.01 s-1; 1.0-1.9 Pa∙s at 200 s-1 |
| Shelf life | Minimum 3 months |
| Storage conditions | 2-10°C, do not freeze |
| Kit components | CELLINK RGD 3×3 mL cartridge CaCl2 Crosslinking Agent, 45 mL |
| Use | For research use only. Not for human use. |
Publications
Mouse in vitro spermatogenesis on alginate-based 3D bioprinted scaffolds
Baert, Y; Dvorakova-Hortova, K; Margaryan, H; Goossens, E. Biofabrication, 11(3), 035011. (2019)
https://iopscience.iop.org/article/10.1088/1758-5090/ab1452/meta
Comparative Analysis of Bioinks in 3D Bioprinted Organoids of Colorectal Cancer
Molander, D; Sbirkov, Y; Bodurov, I; Dikov, D; Sarafian, V. Acta Morphologica et Anthropologica, 29 (3-4). (2022)
http://www.iempam.bas.bg/journals/acta/acta29b/17-21.pdf
A colorectal cancer 3D bioprinting workflow as a platform for disease modeling and chemotherapeutic screening
Sbirkov, Y; Molander, D; Milet, C; Bodurov, I; Atanasov, B; Penkov, R; Belev, N; Forraz, N; McGuckin, C; Sarafian, V. Frontiers in bioengineering and biotechnology, 9. (2021)
https://doi.org/10.3389/fbioe.2021.755563
World’s first long-term colorectal cancer model by 3D bioprinting as a mechanism for screening oncolytic viruses
McGuckin, C; Forraz, N; Milet, C; Lacroix, M; Sbirkov, Y; Sarafian, V; Ebel, C; Spindler, A; Koerper, V; Balloul, J.-M; Quéméneur, E; Zaupa, C. Cancers, 15(19), 4724. (2023)
https://doi.org/10.3390/cancers15194724
